Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion description "[We document an EGFR mutation in a patient with papillary renal cell cancer with a history of multiple therapies, including interferon-alpha, interleukin-2, 5-fluorouracil, and interferon-alpha together with 13-cis-retinoic acid, to which floxuridine was later added, and thalidomide maintenance therapy for six years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion evidence source_evidence_literature NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion SIO_000772 20346742 NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion wasDerivedFrom befree-2016 NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_assertion wasGeneratedBy ECO_0000203 NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.
- befree-2016 importedOn "2016-02-19" NP802840.RAk-_Po_3wah3mt5q4RFfS6LpAKi0bzJe6QDbGFLNmGRs130_provenance.